Press release
The Mexican agricultural biotech company founded in 1957 unveils a new website in 8 languages covering 30+ countries, showcasing its proprietary technologies ECCA Carboxy®, RDR, and PFenergy® and a portfolio of 40+ biorational products.
Innovak Global - Mexican agricultural biotechnology company founded in 1957, pioneer in biostimulation with ECCA Carboxy®, RDR and
biotechnology company founded in 1957 and a pioneer in crop biostimulation,
has launched a new multi-language digital platform available in Spanish,
Portuguese, English, and Turkish across eight international markets: Mexico,
Brazil, Colombia, Chile, Peru, the United States, Turkey, and International.
The new platform at innovakglobal.com serves as a comprehensive resource for
agronomists, distributors, and farmers seeking biorational solutions for
sustainable agriculture. It features the company's full portfolio of 40+ products
organized by technology, crop, and market, along with technical documentation
and agronomic support tools.
"This platform reflects 70 years of agricultural innovation. We want every farmer
in our 30+ markets to have direct access to our technologies and the science
behind them," said Luis Román Medina, CEO of Innovak Global.
Three Proprietary Patented Technologies
Innovak Global's portfolio is built on three technologies developed and patented
over decades of field research:
ECCA Carboxy® - An internationally patented ecotechnology based on Carboxy
Aromatic Compounds (CAC) with organic certification. The only biostimulant with
proven biological effects across three axes: plant nutrition, abiotic stress
management (drought, heat, salinity), and structural crop reinforcement. Developed
in collaboration with the University of Arkansas.
RDR (Root Dynamic Regulation) - A technology platform focused on the root and
its rhizospheric environment. Operates across five domains: soil conditioning,
root stress reduction, root activation, rhizospheric environment improvement,
and root health.
PFenergy® - A precision biostimulation platform based on high-bioavailability
polyphenols. Enhances metabolic, root, and rhizospheric activity for higher
yield and fruit quality, especially in high-value fruits and vegetables.
Global Presence and Market-Specific Solutions
With subsidiaries in Mexico, Brazil, Colombia, Chile, Peru, the United States,
and Turkey, Innovak Global provides tailored biorational solutions for more than
40 crops including corn, wheat, cotton, avocado, grape, tomato, strawberry,
citrus, sugarcane, asparagus, and blueberry.
Recent market expansions include the launch of Kresko® in Brazil - a
cytokinin-based hormonal regulator with an exclusive registration for cotton
crops - and Haddak Plus®, a specialized solution for crops under El Niño
climate stress in Peru, Colombia, and Central America.
Products featuring ECCA Carboxy® technology are listed by the Organic Materials
Review Institute (OMRI), certifying compatibility with international organic
agriculture standards.
Perif. V. L. Toledano 6615
Innovak Global is a Mexican agricultural biotechnology company founded in 1957
by Vicente Medina Holguín in Chihuahua, Mexico. Currently led by the third
generation of the founding family, the company pioneers biostimulation with
proprietary patented technologies ECCA Carboxy®, RDR, and PFenergy®. With a
portfolio of 40+ biorational products and operations in 30+ countries, Innovak
Global is a leading force in sustainable agriculture inputs in Latin America,
North America, and beyond.
Website: https://www.innovakglobal.com
Wikipedia: https://es.wikipedia.org/wiki/Innovak_Global
Wikidata: https://www.wikidata.org/wiki/Q140357503
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release The Mexican agricultural biotech company founded in 1957 unveils a new website in 8 languages covering 30+ countries, showcasing its proprietary technologies ECCA Carboxy®, RDR, and PFenergy® and a portfolio of 40+ biorational products. here
News-ID: 4562234 • Views: …
More Releases for Carboxy
Emerging Sub-Segments Transforming the Carboxy Therapy Market Landscape
The carboxy therapy market is positioned for substantial growth in the coming years as demand for advanced, personalized cosmetic and therapeutic treatments rises. With innovations in technology and a growing focus on non-invasive procedures, this market is attracting significant attention from both practitioners and consumers. Let's explore the market's projected valuation, key players, emerging trends, and detailed segment analysis to understand its future trajectory.
Expected Market Valuation of the Carboxy Therapy…
Emerging Sub-Segments Transforming the Carboxy Therapy Market Landscape
The carboxy therapy market is positioned for substantial growth in the coming years as demand for advanced, personalized cosmetic and therapeutic treatments rises. With innovations in technology and a growing focus on non-invasive procedures, this market is attracting significant attention from both practitioners and consumers. Let's explore the market's projected valuation, key players, emerging trends, and detailed segment analysis to understand its future trajectory.
Expected Market Valuation of the Carboxy Therapy…
Global and European Carboxy Therapy Market Outlook 2025-2035
The global carboxy therapy market is poised for robust expansion through 2035, fueled by rising demand for non-surgical skin rejuvenation, anti-aging treatments, and natural regenerative procedures. According to Future Market Insights (FMI), the market is valued at USD 139.4 million in 2025 and is projected to reach USD 448.7 million by 2035, expanding at a compound annual growth rate (CAGR) of 12.4%.
The FMI report, "Carboxy Therapy Market Size, Share, and…
Carboxy Therapy Market: Prospects for Long-Term Value & Growth
The "Global Carboxy Therapy" intelligence report, just published by USD Analytics, covers insurers' micro-level study of important market niches, product offers, and sales channels. In order to determine market size, potential, growth trends, and competitive environment, the Global Carboxy Therapy provides dynamic views. Both primary and secondary sources of data were used to generate the research, which has both qualitative and quantitative depth. Several of the major figures the study…
Carboxy Therapy Market Is Driven By Carboxy Therapy In Various Industries, Need …
The Demineralized Bone Matrix (DBM) Market is experiencing significant growth in the field of orthopedics and regenerative medicine. DBM is a grafting material derived from human or animal bone, which is processed to remove the inorganic minerals, leaving behind a matrix rich in growth factors and collagen. This makes DBM an invaluable resource in various surgical procedures, particularly in bone repair and spinal fusion surgeries. One of the key drivers…
Carboxy Therapy Market Is Driven By Carboxy Therapy In Various Industries, Need …
The Carboxy Therapy Market is witnessing notable growth and innovation within the field of aesthetic and therapeutic medicine. This non-invasive procedure involves the subcutaneous injection of medical-grade carbon dioxide gas (CO2) to stimulate circulation, improve tissue oxygenation, and trigger collagen production. One of the key drivers behind the expansion of this market is the increasing demand for non-surgical and minimally invasive treatments to address a variety of skin concerns, including…
